Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Type I Hypersensitivity”

151 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 151 results

Not applicableEnded earlyNCT05961163
What this trial is testing

Chronical Illness-related Limitations of the Ability to Cope With Rising Temperatures: an Observational Study

Who this might be right for
Coronary DiseaseMyocardial InfarctionHeart Failure+13 more
Universitätsklinikum Hamburg-Eppendorf 61
Testing effectiveness (Phase 2)Looking for participantsNCT05003986
What this trial is testing

Study of Sparsentan Treatment in Pediatrics With Proteinuric Glomerular Diseases

Who this might be right for
Focal Segmental GlomerulosclerosisMinimal Change DiseaseImmunoglobulin A Nephropathy+2 more
Travere Therapeutics, Inc. 67
Testing effectiveness (Phase 2)Study completedNCT00133159
What this trial is testing

Different Doses of Tyrosine Adsorbed Grass Pollen Allergoid With Monophosphoryl Lipid A (MPL) in Patients Sensitized to Grass Pollen

Who this might be right for
Type I Hypersensitivity
Allergy Therapeutics 68
Testing effectiveness (Phase 2)Study completedNCT00113750
What this trial is testing

Induction of Immunogenicity With Different Doses of TreeMATA in Subjects Allergic to Tree Pollen

Who this might be right for
Type I Hypersensitivity
Allergy Therapeutics 70
Large-scale testing (Phase 3)Study completedNCT06467084
What this trial is testing

Open-Label Safety, PK, and Efficacy Trial of Sebetralstat (KVD900) in Pediatric Patients (Ages 2-11) With HAE Type I or II

Who this might be right for
Hereditary Angioedema
KalVista Pharmaceuticals, Ltd. 36
Early research (Phase 1)UnknownNCT04029909
What this trial is testing

A Clinical Study of Gimatecan in Advanced Ovarian Epithelial Cancer, Fallopian Tube Cancer or Primary Peritoneal Cancer

Who this might be right for
Ovarian Epithelial CancerFallopian Tube CancerPrimary Peritoneal Cancer
Lee's Pharmaceutical Limited 12
Large-scale testing (Phase 3)Study completedNCT00912093
What this trial is testing

Icatibant in Patients With Acute Attacks of Hereditary Angioedema (FAST-3)

Who this might be right for
Hereditary Angioedema
Shire 98
Not applicableStudy completedNCT06065137
What this trial is testing

Standardised Drug Provocation Testing in Perioperative Hypersensitivity

Who this might be right for
Allergic ReactionHypersensitivityPerioperative Complication+4 more
University Hospital, Antwerp 50
Post-approval studies (Phase 4)Study completedNCT00875082
What this trial is testing

Effect of Montelukast on Remodelling Markers in Asthmatic Children

Who this might be right for
Asthma
Universita di Verona 30
Testing effectiveness (Phase 2)Ended earlyNCT00387478
What this trial is testing

Investigation of Efficacy and Safety of Tree MATAMPL,Tree MATA, and Placebo in Patients With Birch-Induced Seasonal Allergic Rhinitis

Who this might be right for
Type I Hypersensitivity
Allergy Therapeutics 121
Not applicableApproved For MarketingNCT06628713
What this trial is testing

Treatment of Angioedema Attacks in Adolescent and Adult Patients 12 Years and Older With HAE Type I or II With Sebetralstat

Who this might be right for
Hereditary Angioedema
KalVista Pharmaceuticals, Ltd.
Post-approval studies (Phase 4)Study completedNCT01467947
What this trial is testing

Postmarketing Immunogenicity Study in HAE Subjects Treated With Berinert

Who this might be right for
Hereditary Angioedema Types I and II
CSL Behring 46
Testing effectiveness (Phase 2)Study completedNCT00258635
What this trial is testing

Investigation of Safety+Efficacy of Different Doses of RagweedMATAMPL;Assessment of Residual Allergenicity Using Skin Prick Test

Who this might be right for
Type I Hypersensitivity
Allergy Therapeutics 69
Not applicableStudy completedNCT07009262
What this trial is testing

A Study Observing US Patients With HAE Type I or II Who Take Icatibant to Treat HAE Attacks

Who this might be right for
Hereditary Angioedema
KalVista Pharmaceuticals, Ltd. 88
Early research (Phase 1)Study completedNCT01730417
What this trial is testing

Phase I Study of the Safety, Distribution, and Radiation Dosimetry of Ultratrace Iobenguane 123I-mIBG

Who this might be right for
Neuroendocrine TumorsHeart Failure
Bennett Chin 12
Testing effectiveness (Phase 2)Study completedNCT00325338
What this trial is testing

Follow-up Investigation of Efficacy of Ragweed MATAMPL,and Placebo in Patients With Ragweed-induced Seasonal Allergic Rhinitis

Who this might be right for
Type I Hypersensitivity
Allergy Therapeutics 100
Not applicableStudy completedNCT04861090
What this trial is testing

A Study in Teenagers and Adults With Hereditary Angioedema (HAE) Type I or Type II Who Use Lanadelumab as Long-Term Prophylaxis

Who this might be right for
Hereditary Angioedema (HAE)
Takeda 207
Post-approval studies (Phase 4)UnknownNCT01159379
What this trial is testing

Safety of Ertapenem in Beta-lactam Allergic Patients.

Who this might be right for
IgE-Mediated HypersensitivityAllergy
Catholic University of the Sacred Heart 30
Early research (Phase 1)Looking for participantsNCT07369505
What this trial is testing

Sapu003 in Advanced mTOR-sensitive Solid Tumors

Who this might be right for
Breast Cancer MetastaticRenal Cell Carcinoma (RCC)Neuroendocrine Tumors+2 more
SAPU NANO (US) LLC 27
Not applicableLooking for participantsNCT07638345
What this trial is testing

DASH-Obesity: Explainable AI for Family-Centric Personalized Weight Control in Adolescents and Young Adults With Obesity and Chronic Conditions

Who this might be right for
Type 1 DiabetesT1DObesity & Overweight+3 more
Adhera Health, Inc. 280
Next Page